Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2010
03/11/2010CA2735842A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010CA2735795A1 Novel inhibitors
03/11/2010CA2735794A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010CA2735779A1 Bicyclic kinase inhibitors
03/11/2010CA2735770A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
03/11/2010CA2735208A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2160390A1 Novel process
03/10/2010EP2160388A2 Arylamide pyrimidone compounds
03/10/2010EP2160387A2 Heteroarylamide pyrimidone compounds
03/10/2010EP2160381A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
03/10/2010EP2029558B1 Compounds and methods for modulating fxr
03/10/2010EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
03/10/2010EP1786801B1 2-arylcarbamoyl-indoles as cytokine inhibitors
03/10/2010EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia
03/10/2010EP1423376B1 Bicyclic compound, production and use thereof
03/10/2010CN101665486A Method for preparing 4-amino-3,5-di(1-imidazolemethyl)-4-hydro-1,2,4-triazole
03/09/2010US7674913 Heterocyclic boronic acid compounds
03/09/2010US7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674802 leukotriene A4 hydrolase inhibitors; biaryl nitrogen-attached heterocycles
03/09/2010US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
03/09/2010US7674796 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2329292C A process for the manufacture of sulfonylaminocarbonyl triazolinones and salts thereof under ph controlled conditions
03/09/2010CA2306313C Dipeptide nitriles
03/09/2010CA2140598C Prolineamide derivatives
03/04/2010WO2010025436A2 Nitrogen and sulfur-containing heterocycle derivatives
03/04/2010WO2010025138A2 Pyrimidine compounds
03/04/2010WO2010024586A2 Novel benzamide derivative compound, and a method for producing same
03/04/2010WO2010024572A2 Material for organic photoelectric device and organic photoelectric device including the same
03/04/2010WO2010024430A1 2,4-diaminopyrimidine compound
03/04/2010WO2010024227A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/04/2010WO2010023946A1 Novel uracil compound having nitrogenated heterocyclic ring or salt thereof
03/04/2010WO2010023474A1 Novel polymorphs of sunitinib and processes for their preparation
03/04/2010WO2010023473A2 Novel crystalline form and processes for its preparation
03/04/2010WO2010023446A1 Novel potassium channel blockers
03/04/2010WO2010023445A1 Novel potassium channel blocker
03/04/2010WO2009145591A3 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
03/04/2010WO2009117484A3 Small molecule e2f inhibitor
03/04/2010WO2009106471A3 Angiotensin ii receptor blocker derivatives
03/04/2010US20100056783 Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof
03/04/2010US20100056776 Method of preparing macromolecular contrast agents and uses thereof
03/04/2010US20100056600 11beta-hsd1 active compounds
03/04/2010US20100056597 Indoledione derivative
03/04/2010US20100056593 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds
03/04/2010US20100056544 Salts with CRTH2 Antagonist Activity
03/04/2010US20100056543 Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof
03/04/2010US20100056542 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056535 Inhibitors of HIV-1 reverse transcriptase
03/04/2010US20100056524 Compound
03/04/2010US20100056518 Cycloalkylamine substituted isoquinolone derivatives
03/04/2010US20100056505 Substituted Pyrazalones
03/04/2010US20100056498 Substituted monocyclic cgrp receptor antagonists
03/04/2010US20100056494 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
03/04/2010US20100055071 Anti-Viral Compounds
03/04/2010US20100052526 Pyrene compounds and organic electroluminescent devices using the same
03/04/2010CA2735730A1 2,4-diaminopyrimidine compound
03/04/2010CA2735084A1 Novel polymorphs of sunitinib and processes for their preparation
03/04/2010CA2734965A1 Novel crystalline form and processes for its preparation
03/04/2010CA2733648A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/03/2010EP2158195A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders
03/03/2010EP2158194A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
03/03/2010EP2081572B1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
03/03/2010EP1753719B1 Substituted pyrrolidine-2-ones
03/03/2010CN101663295A Aminopyrimidines useful as inhibitors of protein kinases
03/03/2010CN101663294A Process for hcv protease inhibitor intermediate
03/03/2010CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/02/2010US7671214 Modification of the indolium ring to permit a reactive group or conjugated substance at the 3 ring position unexpectedly mitigates the problems of quenching, difficulty in preparing, strong tendency to self-associate (stack); fluorescent dyes; biomarking; uniformity; intensity; photostability
03/02/2010US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis
03/02/2010US7671063 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
03/02/2010US7671047 Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
02/2010
02/25/2010WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010021878A1 Cold menthol receptor antagonists
02/25/2010WO2010020810A1 2-(imidaz0lylamin0)-pyridine derivatives and their use as jak kinase inhibitors
02/25/2010WO2010020762A1 1,5-diaryl-pyrazoles and their use as cannabinoid receptor neutral antagonists
02/25/2010WO2010020432A2 Compounds for treatment of duchenne muscular dystrophy
02/25/2010WO2010020366A1 Azabicyclic substituted 5-aminopyrazoles and the use thereof
02/25/2010WO2010020363A1 Substituted 5-aminopyrazoles and use thereof
02/25/2010WO2009158571A8 Heteroaryl compounds and uses thereof
02/25/2010WO2009155001A3 Wnt protein signalling inhibitors
02/25/2010WO2009151899A3 Preparation of imatinib mesylate
02/25/2010WO2002068414A8 Analogs of thalidomide as potential angiogenesis inhibitors
02/25/2010US20100048895 Process for Preparing Heterocyclic Derivatives
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048890 Conjugated small molecules
02/25/2010US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
02/25/2010US20100048596 Indole Derivatives as Antitumoral Compounds
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048586 Multifunctional bioactive compounds
02/25/2010US20100048580 Histamine h3 receptor agents, preparation and therapeutic uses
02/25/2010US20100048578 Hydrazide compound and harmful arthropod-controlling agent containing the same
02/25/2010US20100048576 PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS
02/25/2010US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors
02/25/2010US20100048567 Inhibitors of syk and JAK protein kinases
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 626